Clinical trial
Study of PRN and Every 2months Intravitreal Aflibercept After 3 Initial Monthly Injection for Age Related Macular Degeneration
NCT01824225 is registered in ClinicalTrials.gov with Nihon University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study of PRN and Every 2months Intravitreal Aflibercept After 3 Initial Monthly Injection for Age Related Macular Degeneration
- Lead sponsor
- Nihon University
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2013
- Completion date
- March 31, 2015
- Enrollment
- 100 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
age-related macular degeneration